共 50 条
- [1] LONG-TERM USE OF ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2024, 44 (02): : 222 - 229
- [2] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (08):
- [3] Anti-vascular endothelial growth factor for neovascular age-related macular degeneration [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (03):
- [7] EPIRETINAL MEMBRANES IN NEOVASCULAR AGE-RELATED MACULAR DEGENERATION Effect on Outcomes of Anti-vascular Endothelial Growth Factor Therapy [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2015, 35 (08): : 1540 - 1546
- [8] Implications of discontinuing anti-vascular endothelial growth factor therapy in neovascular age-related macular degeneration [J]. CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2022, 49 (08): : 956 - 956
- [9] Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration [J]. COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2008, (02):
- [10] LONG-TERM REMISSION OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION WITH AS-NEEDED ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY [J]. RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2018, 38 (03): : 516 - 522